|
| 36470426 | Mapping the KRAS proteoform landscape in colorectal cancer identifies truncated KRAS4B that decreases MAPK signaling. | J Biol Chem | 2023 |
| 36470426 | Mapping the KRAS proteoform landscape in colorectal cancer identifies truncated KRAS4B that decreases MAPK signaling. | J Biol Chem | 2023 |
| 36001024 | Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. | Cancer Discov | 2022 |
| 36001024 | Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. | Cancer Discov | 2022 |
| 33417831 | Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. | Cancer Cell | 2021 |
| 33577785 | Proteogenomic and metabolomic characterization of human glioblastoma. | Cancer Cell | 2021 |
| 33417831 | Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. | Cancer Cell | 2021 |
| 34858420 | Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens. | Front Immunol | 2021 |
| 34671754 | Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. | Cell Rep Methods | 2021 |
| 34359745 | Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. | Cancers (Basel) | 2021 |
| 33577785 | Proteogenomic and metabolomic characterization of human glioblastoma. | Cancer Cell | 2021 |
| 34858420 | Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens. | Front Immunol | 2021 |
| 34671754 | Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. | Cell Rep Methods | 2021 |
| 34359745 | Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition. | Cancers (Basel) | 2021 |
| 31923397 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. | Cell | 2020 |
| 32058701 | Deep Proteomics Using Two Dimensional Data Independent Acquisition Mass Spectrometry. | Anal Chem | 2020 |
| 31923397 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. | Cell | 2020 |
| 32058701 | Deep Proteomics Using Two Dimensional Data Independent Acquisition Mass Spectrometry. | Anal Chem | 2020 |
| 31467290 | A dataset describing a suite of novel antibody reagents for the RAS signaling network. | Sci Data | 2019 |
| 31675502 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. | Cell | 2019 |
| 31467290 | A dataset describing a suite of novel antibody reagents for the RAS signaling network. | Sci Data | 2019 |
| 31675502 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. | Cell | 2019 |
| 29474155 | A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage. | Radiat Res | 2018 |
| 29928062 | Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells. | PLoS One | 2018 |
| 29474155 | A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage. | Radiat Res | 2018 |
| 29928062 | Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells. | PLoS One | 2018 |
| 29124938 | Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues. | J Proteome Res | 2017 |
| 29124938 | Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues. | J Proteome Res | 2017 |
| 26867747 | Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays. | Methods Mol Biol | 2016 |
| 27372738 | Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. | Cell | 2016 |
| 26867747 | Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays. | Methods Mol Biol | 2016 |
| 26719571 | Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays. | Clin Chem | 2016 |
| 27595404 | A proposal for validation of antibodies. | Nat Methods | 2016 |
| 27595404 | A proposal for validation of antibodies. | Nat Methods | 2016 |
| 27372738 | Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. | Cell | 2016 |
| 26719571 | Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays. | Clin Chem | 2016 |
| 25187343 | Linking cancer genome to proteome: NCI's investment into proteogenomics. | Proteomics | 2014 |
| 25187343 | Linking cancer genome to proteome: NCI's investment into proteogenomics. | Proteomics | 2014 |
| 20715861 | Evolution of clinical proteomics and its role in medicine. | J Proteome Res | 2011 |
| 29768786 | Realizing individualized medicine: the road to translating proteomics from the laboratory to the clinic. | Per Med | 2011 |
| 20715861 | Evolution of clinical proteomics and its role in medicine. | J Proteome Res | 2011 |
| 29768786 | Realizing individualized medicine: the road to translating proteomics from the laboratory to the clinic. | Per Med | 2011 |
| 19674966 | A community standard format for the representation of protein affinity reagents. | Mol Cell Proteomics | 2010 |
| 19674966 | A community standard format for the representation of protein affinity reagents. | Mol Cell Proteomics | 2010 |
| 21142883 | A synopsis of the 3rd annual Cancer Proteomics Conference. | Expert Rev Proteomics | 2010 |
| 21137031 | Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: an NCI-CPTC initiative perspective. | Proteomics Clin Appl | 2010 |
| 21133699 | Restructuring proteomics through verification. | Biomark Med | 2010 |
| 20007859 | Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics. | Clin Chem | 2010 |
| 20007858 | Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration. | Clin Chem | 2010 |
| 21142883 | A synopsis of the 3rd annual Cancer Proteomics Conference. | Expert Rev Proteomics | 2010 |